ArticleJSES international2025
Forgotten Shoulder ASAP-22: a scapula-inclusive shoulder ecosystem PROM-Pilot study in reverse total shoulder arthroplasty and related pathologies.
Article in JSES international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Refining Reverse Shoulder Arthroplasty: From Implant Design to Patient-Specific Strategy.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reverse total shoulder arthroplasty (rTSA) is now the most commonly performed type of shoulder arthroplasty. However, most legacy patient-reported outcome measures (PROMs) were developed before the widespread adoption of rTSA and often fail to address its unique challenges-particularly those related to altered scapular mechanics, rotational limitations, and instability. The Forgotten Shoulder Adaptive Scapula Analytics and Performance Score (FS ASAP-22) was developed to fill these gaps, utilizing an adaptive scoring model grounded in the "forgotten joint" concept. To our knowledge, it is the first PROM to include a dedicated domain for posture and scapular mechanics. We hypothesized that the FS ASAP-22 would show strong correlations with established PROMs while minimizing ceiling effects and providing enhanced granularity and clinical relevance. Methods: In this pilot study, 30 patients with shoulder conditions relevant to rTSA completed the FS ASAP-22, American Shoulder and Elbow Surgeons (ASES) score, and Subjective Shoulder Value (SSV). The FS ASAP-22 includes 22 items across 10 domains covering pain, night pain, internal rotation, external rotation, overhead reach, range of motion (stiffness), strength, function, instability, and scapula assessment. We assessed internal consistency (Cronbach's alpha), construct validity (Spearman's correlation), and missing data. An adaptive scoring system was used for tasks that could not be performed due to reasons unrelated to the shoulder. Results: The mean FS ASAP-22 score was 69 ± 13 (range 20-94), compared to ASES (72 ± 16) and SSV (69 ± 19). The FS ASAP-22 showed no ceiling effect and a lower median score (65), with no clustering among high-functioning patients. Internal consistency was high across most domains (α = 0.84-0.94), and construct validity was strong, with correlations to ASES (ρ = 0.82) and SSV (ρ = 0.84). Domains addressing rotation and scapular mechanics provided unique insights into active rotation in space, patient posture, and scapular pain distribution. These aspects are not captured by legacy scores. The instability domain showed poor internal consistency, likely due to low symptom prevalence. Only 2.6% of responses were missing (17 of 660), supporting the feasibility of the adaptive forma. Conclusion: The FS ASAP-22 demonstrates strong initial construct validity and high consistency of most domains. Its domain-specific, adaptive structure addresses key limitations of traditional PROMs. Strong correlations with ASES and SSV support backward compatibility with historical data, while the inclusion of novel domains may enhance longitudinal tracking and patient care. Further validation in larger and disease-specific cohorts is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.